BioNTech : and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies - Form 6-K

BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies





•Collaboration leverages BioNTech's... | January 10, 2022

Related Keywords

United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Melanie Toyne Sewell ,Nathan Billis ,Theodora Harold ,Fosun Pharma ,Sylke Maas ,Katie Duffell ,Michael Booth ,Ugur Sahin ,Genentech ,Zai Lab ,Bayer Animal Health ,Pfizer ,Ip Group ,Cancer Research United Kingdom ,Roche Group ,Crescendo Biologics Ltd ,Crescendo Biologics ,Chief Executive Officer ,New Technologies ,Sofinnova Partners ,Andera Partners ,Takeda Ventures ,Quan Capital ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Year Ended December ,Biontech Se Stock Exchange ,News ,Information ,Press Release ,Iontech ,End ,Rescendo ,Iologics ,Nnounce ,Lobal ,Collaboration ,O ,Evelop ,Precision ,Everages Bntx Us09075v1026 ,